Form 4: CFO Ben Taylor Sells RXRX Shares for Tax Obligations

Recursion Pharmaceuticals CFO Ben Taylor disposed of 2,271 Class A Common Stock shares to cover tax withholding obligations related to restricted stock units.

Summary

• Ben R Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc. (RXRX), reported a transaction on November 25, 2025.
• The transaction involved the disposition of 2,271 shares of Class A Common Stock.
• These shares were withheld by the Issuer to satisfy tax withholding and remittance obligations associated with the net settlement of restricted stock units.
• The price per share for the disposed securities was $4.03.
• Following this transaction, Ben R Taylor beneficially owns 789,990 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction represents a routine disposition of shares to cover tax withholding obligations upon the vesting of restricted stock units, which is a standard practice for executive compensation and does not reflect a discretionary sale or purchase.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related disposition, not a discretionary sale indicating a change in management's view of the company's prospects.

Key Dates

Keywords

Recursion Pharmaceuticals, RXRX, Ben R Taylor, CFO, Insider Transaction, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Equity Compensation